Monday, September 23, 2019
- 1:45pm-3:15pm
-
Quantification of regional iron content with Susceptibility Weighted Imaging in Huntington Disease Expansion Gene Carriers
Huntington’s Disease · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Quantitative evaluation of gait ataxia of Multiple System Atrophy patients
Ataxia · Les Muses, Level 3
- 1:45pm-3:15pm
-
Quantitative Motor (Q-Motor) Assessments Suggest a Beneficial Central Effect of Laquinimod in a Phase II Study in Huntington Disease (LEGATO-HD)
Huntington’s Disease · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Quantitative study of subthalamic ERG potassium channels in parkinsonian discharges
Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Quercetin Regulates Cadmium Induced Motor Dysfunction in Depletion of Dopamine and its Metabolites at Synapse
Neuropharmacology · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Randomized, placebo-controlled, double-blind, two-period cross-over study to evaluate the safety, tolerability, and efficacy of a novel treatment combination for levodopa induced dyskinesia in Parkinson’s Disease (BUS-PD)
Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Rapidly onset progressive generalised dystonia parkinsonism in a young Indian male with rare FBXO 7 genetic mutation
Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Rare causes of Opsoclonus Myoclonus Ataxia Syndrome
Myoclonus · Les Muses, Level 3
- 1:45pm-3:15pm
-
Relationship Between Handgrip and Functional Mobility in a Brazilian Parkinsonian Elderly Population
Physical and Occupational Therapy · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Relationship between parkinsonism and upper extremity function in patients with Parkinson’s disease
Physical and Occupational Therapy · Les Muses Terrace, Level 3
- «Previous Page
- 1
- …
- 54
- 55
- 56
- 57
- 58
- …
- 75
- Next Page»